- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 188,385,830
- Share change
- +1,279,946
- Total reported value
- $58,970,231,587
- Put/Call ratio
- 114%
- Price per share
- $313.12
- Number of holders
- 1,011
- Value change
- +$472,002,826
- Number of buys
- 466
- Number of sells
- 421
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
12%
|
18,107,358
|
$4,913,612,000 | — | 30 Jun 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
10%
|
15,391,401
|
$4,176,611,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
14,534,827
|
$3,944,171,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
6.6%
|
9,721,312
|
$2,637,973,000 | — | 30 Jun 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
6.3%
|
9,293,900
|
$2,521,993,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.1%
|
8,948,782
|
$2,428,341,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
4.2%
|
6,104,026
|
$1,656,390,000 | — | 30 Jun 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
5,228,480
|
$1,418,801,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
2.3%
|
3,440,738
|
$933,681,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.1%
|
3,017,136
|
$818,731,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
2,419,526
|
$655,568,000 | — | 30 Jun 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.6%
|
2,403,747
|
$652,281,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
2,276,301
|
$617,696,000 | — | 30 Jun 2017 | |
| Jackson Square Partners, LLC |
13F
|
Company |
1.4%
|
2,057,727
|
$558,384,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
2,014,477
|
$546,648,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
2,004,466
|
$543,932,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,906,820
|
$517,434,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
1,875,780
|
$509,011,000 | — | 30 Jun 2017 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.3%
|
1,839,582
|
$499,189,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,733,493
|
$470,401,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
1,709,010
|
$463,777,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
1,665,576
|
$451,965,000 | — | 30 Jun 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.1%
|
1,630,000
|
$442,317,000 | — | 30 Jun 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.98%
|
1,445,560
|
$392,265,000 | — | 30 Jun 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.96%
|
1,416,237
|
$384,309,000 | — | 30 Jun 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.89%
|
1,305,858
|
$354,357,000 | — | 30 Jun 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.89%
|
1,304,659
|
$354,032,000 | — | 30 Jun 2017 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
1,278,163
|
$346,842,000 | — | 30 Jun 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.81%
|
1,188,575
|
$322,532,000 | — | 30 Jun 2017 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.74%
|
1,087,357
|
$295,065,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.73%
|
1,079,277
|
$292,874,000 | — | 30 Jun 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.73%
|
1,072,719
|
$291,095,000 | — | 30 Jun 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.73%
|
1,066,566
|
$289,423,000 | — | 30 Jun 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.7%
|
1,025,107
|
$278,172,000 | — | 30 Jun 2017 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.66%
|
966,054
|
$262,148,000 | — | 30 Jun 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.61%
|
892,101
|
$242,081,000 | — | 30 Jun 2017 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.58%
|
846,152
|
$229,612,000 | — | 30 Jun 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.56%
|
829,144
|
$224,996,516 | — | 30 Jun 2017 | |
| MANNING & NAPIER ADVISORS LLC |
13F
|
Company |
0.55%
|
814,369
|
$220,986,000 | — | 30 Jun 2017 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.55%
|
810,301
|
$219,883,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
798,469
|
$216,673,000 | — | 30 Jun 2017 | |
| Swiss National Bank |
13F
|
Company |
0.54%
|
788,899
|
$214,076,000 | — | 30 Jun 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
762,861
|
$207,010,000 | — | 30 Jun 2017 | |
| Winslow Capital Management, LLC |
13F
|
Company |
0.49%
|
726,394
|
$197,114,000 | — | 30 Jun 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.49%
|
719,122
|
$195,141,000 | — | 30 Jun 2017 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.48%
|
710,500
|
$192,801,000 | — | 30 Jun 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.48%
|
705,998
|
$191,579,000 | — | 30 Jun 2017 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.47%
|
688,495
|
$186,830,000 | — | 30 Jun 2017 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.42%
|
622,430
|
$168,903,000 | — | 30 Jun 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.42%
|
616,737
|
$167,358,000 | — | 30 Jun 2017 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2017
As of 30 Sep 2017,
BIOGEN INC. - Common Stock (BIIB) was held by
1,011 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
188,385,830 shares.
The largest 10 holders included
BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Clearbridge Investments, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., and NORTHERN TRUST CORP.
This page lists
1,012
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
991
Q3 2017 holders
1,011
Holder diff
20
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.